Efficacy and Safety of Radiotherapy Combined with Chemoimmunotherapy vs. Chemoimmunotherapy Alone as First-Line Treatment for Advanced Esophageal Squamous Cell Carcinoma with Oligorecurrence

被引：0
|
作者：
Lv, X. [1 ]
Wang, Y. [1 ]
Ai, J. [1 ]
Wang, Q. [1 ]
Wang, J. [2 ]
机构：
[1] Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China
[2] Hebei Med Univ, Hosp 4, Dept Radiat Oncol, Shijiazhuang, Hebei, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3089
引用
收藏
页码：E493 / E493
页数：1
相关论文
共 50 条
  • [1] Radiotherapy Combined with Chemoimmunotherapy vs. Chemoimmunotherapy Alone as First-Line Treatment for Advanced Esophageal Squamous Cell Carcinoma with Oligometastasis at Initial Diagnosis
    Lv, X.
    Wang, S.
    Zhang, W.
    Pang, Q.
    Lin, Q.
    Wu, Y.
    Hui, Z.
    Liu, Y.
    Cheng, Y.
    Liu, Q.
    Wang, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E493 - E494
  • [2] Radiotherapy combined with chemoimmunotherapy improves survival compared to chemoimmunotherapy alone as first-line treatment for oligometastatic esophageal squamous cell carcinoma
    Lv, Xiaoyan
    Wang, Shuai
    Zhang, Wencheng
    Pang, Qingsong
    Lin, Qiang
    Wu, Yajing
    Hui, Zhouguang
    Liu, Yueping
    Cheng, Yunjie
    Liu, Qing
    Wang, Jun
    STRAHLENTHERAPIE UND ONKOLOGIE, 2025,
  • [3] Comparison of Efficacy and Safety of First-Line Chemoimmunotherapy in Advanced Esophageal Squamous Cell Carcinoma: A Systematic Review and Network Meta-Analysis
    Ma, Xiaolu
    Ding, Yongfeng
    Qian, Jiong
    Wan, Mingyu
    Chen, Xiaoyu
    Xu, Nong
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2023, 2023
  • [4] Chemoimmunotherapy plus radiotherapy in advanced esophageal squamous-cell carcinoma
    Han, Xiang
    Zhang, Ling
    Hou, Qiuyu
    Ji, Youxin
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 437 - 437
  • [5] Neoadjuvant Chemoradiotherapy vs Chemoimmunotherapy for Esophageal Squamous Cell Carcinoma
    Guo, Xufeng
    Chen, Chunji
    Zhao, Jinbo
    Wang, Changchun
    Mei, Xinyu
    Shen, Jianfei
    Lv, Huilai
    Han, Yongtao
    Wang, Qifeng
    Lv, Jiahua
    Chen, Hainan
    Yan, Xiaolong
    Liu, Zhichao
    Zhang, Zhengyang
    Zhong, Qihong
    Jiang, Youhua
    Xu, Liwei
    Li, Xiaoyang
    Qian, Dong
    Ma, Dehua
    Ye, Minhua
    Wang, Chunguo
    Wang, Zimin
    Lin, Jiangbo
    Tian, Ziqiang
    Leng, Xuefeng
    Li, Zhigang
    JAMA SURGERY, 2025,
  • [6] The efficacy and safety of sintilimab combined with chemotherapy as the first-line treatment for metastatic esophageal squamous cell carcinoma
    Zhao, Zheng
    Yin, Ming-Mei
    Zhao, Wei-Feng
    Wang, Chao-Jie
    MEDICINE, 2023, 102 (33) : E34794
  • [7] Efficacy and Safety of Neoadjuvant Chemoimmunotherapy in Resectable Esophageal Squamous Cell Carcinoma: A Meta-analysis
    Xu, Jinxin
    Yan, Chun
    Li, Zhe
    Cao, Yunpeng
    Duan, Hongbing
    Ke, Sunkui
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (03) : 1597 - 1613
  • [8] Efficacy and safety of chemotherapy regimens for first-line treatment of advanced esophageal squamous cell carcinoma in Asia: a systematic review
    Xu, Jianming
    Bai, Yuxian
    Li, Enxiao
    Xu, Nong
    Shi, Danfeng
    Qian, Jing
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (09) : 981 - 998
  • [9] The efficacy and toxicities of combined lobaplatin with paclitaxel as a first-line chemotherapy for advanced esophageal squamous cell carcinoma
    Chen, Ming-Qiu
    Chen, Cheng
    Lu, Hai-Jie
    Xu, Ben-Hua
    JOURNAL OF THORACIC DISEASE, 2015, 7 (10) : 1749 - 1755
  • [10] Efficacy and Safety of Neoadjuvant Chemoimmunotherapy in Resectable Esophageal Squamous Cell Carcinoma: A Meta-analysis
    Jinxin Xu
    Chun Yan
    Zhe Li
    Yunpeng Cao
    Hongbing Duan
    Sunkui Ke
    Annals of Surgical Oncology, 2023, 30 (3) : 1597 - 1613
12345